Following the Supreme Court's 2021 decision striking down the FTC's practice of using FTC Act Section 13(b) to obtain monetary redress in AMG Capital Mgmt., LLC v. FTC, 141 S. Ct. 1341.
The Federal Trade Commission just issued a Notice of Penalty Offenses Concerning Substantiation of Product Claims to nearly 700 marketers of OTC drugs, homeopathic products.
After last year's U.S. Supreme Court decision limiting the Federal Trade Commission's ability to obtain financial relief, the FTC has been forced to look for new ways to give teeth to its.
Continuing our series on the FTC's Notice of Penalty Offenses Concerning Endorsements, this post considers the FTC's statement that it is unlawful under Section 5 of the FTC Act.